CLVS

Clovis Oncology, Inc.
CLVS

Overview Fund Activity
Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

138 hedge funds and large institutions have $1.31B invested in Clovis Oncology, Inc. in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
-2
Holders Change %
-1.43%
% of All Funds
4.01%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
23
Increased
58
Reduced
38
Closed
25
Calls
$31M
Puts
$24.6M
Net Calls
+$6.38M
Net Calls Change
+$17.3M

Top Buyers

1
PHS
1
PFM Health Sciences
California
$57.6M
2
PAI
2
Palo Alto Investors
California
$78.1M
3
O
3
OppenheimerFunds
New York
$80.6M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$65.5M
5
BA
5
BlackRock Advisors
Delaware
$14.1M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$167M
2
BBA
2
Baker Bros. Advisors
New York
$0
3
Franklin Resources
3
Franklin Resources
California
$0
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$0
5
Norges Bank
5
Norges Bank
Norway
$4.89M
Name Holding Trade Value Shares
Change 		Shares
Change %
VOYA Investment Management
26
VOYA Investment Management
Georgia
$11.7M +$2.27M +50,062 +24%
FCM
27
Farallon Capital Management
California
$10.2M – – –
Citadel Advisors
28
Citadel Advisors
Florida
$9.3M +$8.85M +195,069 +1,952%
CCI
29
Columbus Circle Investors
$8.63M +$5.85M +129,068 +211%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$8.01M -$8.28M -182,521 -51%
Millennium Management
31
Millennium Management
New York
$7.88M +$5.01M +110,402 +175%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$7.6M +$208K +4,579 +3%
Balyasny Asset Management
33
Balyasny Asset Management
Illinois
$7.54M +$4.56M +100,533 +153%
Invesco
34
Invesco
Georgia
$6.93M +$452K +9,964 +7%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$6.26M +$234K +5,151 +4%
OM
36
Opaleye Management
Massachusetts
$6.21M +$444K +10,000 +8%
Morgan Stanley
37
Morgan Stanley
New York
$5.84M +$4.27M +94,161 +273%
CS
38
Credit Suisse
Switzerland
$5.74M +$162K +3,563 +3%
TCIM
39
TIAA CREF Investment Management
New York
$5.73M -$83.2K -1,834 -1%
CC
40
CQS Cayman
Cayman Islands
$5.67M +$5.67M +125,000 New
U
41
UBS
Switzerland
$5.52M +$3.1M +68,356 +128%
Norges Bank
42
Norges Bank
Norway
$4.89M -$11.2M -246,223 -70%
TCM
43
Tekla Capital Management
Massachusetts
$4.72M +$2.57M +56,687 +120%
SFM
44
Sphera Funds Management
Israel
$4.63M -$138K -3,045 -3%
CM
45
Corvex Management
New York
$4.25M +$4.25M +93,586 New
BIM
46
BlackRock Investment Management
Delaware
$3.92M +$863K +19,032 +28%
GC
47
Guggenheim Capital
Illinois
$3.86M +$122K +2,686 +3%
Deutsche Bank
48
Deutsche Bank
Germany
$3.8M +$183K +4,032 +5%
Charles Schwab
49
Charles Schwab
California
$3.37M +$237K +5,233 +8%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$3.25M -$2.35M -51,829 -42%
1
2
3 4 5